Experimental Study of Neuroprotective Properties of Inhaled Argon-Oxygen Mixture in a Photoinduced Ischemic Stroke Model

Acute ischemic stroke is a serious problem for healthcare systems worldwide. Searching for the optimal neuroprotector is a contemporary challenge. Various studies have demonstrated neuroprotective properties of argon in ischemic brain damage models. However, the published data are inconsistent.The aim of the study was to evaluate the effect of 24-hour argon-oxygen mixture (Ar 70%/O₂ 30%) inhalation on the severity of neurological deficit and the extent of brain damage in rats after a photoinduced ischemic stroke. Material and methods. The experiments were carried out on male Wistar rats weighing 430–530 g (N=26). Focal ischemic stroke was modeled in the sensorimotor cortex of the rat brain using photochemically induced vascular thrombosis. The animals were randomly divided into 3 groups: sham procedure + N₂ 70%/O₂ 30% inhalation (SP, N=6); stroke + N₂ 70%/O₂ 30% inhalation (Stroke, N=10); Stroke + Ar 70%/O₂ 30% inhalation (Stroke+iAr, N=10). The limb placement test (LPT) was used for neurological assessment during 14 days. Additionally, on day 14 after the stroke, brain MRI with lesion size morphometry was performed. Summarized for days 3,7 and 14 LPT scores were lower in the Stroke and Stroke + iAr groups as compared to the SP group.Results. Statistically significant differences in LPT scores between SP, Stroke, and Stroke+iAr groups were revealed on day 3 post-stroke: (scores: 14 (13; 14), 6.5 (4; 8), and 5 (3; 8), respectively, P=0.027). However, there was no statistical difference between the Stroke and Stroke+iAr groups.Conclusion. 24-hour inhalation of argon-oxygen mixture (Ar 70%/O₂ 30%) after stroke does not reduce the extent of brain damage or the severity of neurological deficit.

[1]  O. Grebenchikov,et al.  Organoprotective Properties of Argon (Review) , 2022, General Reanimatology.

[2]  A. Simion,et al.  Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies , 2021, International journal of molecular sciences.

[3]  O. Grebenchikov,et al.  Effect of Lithium Chloride Concentration on Its Neuroprotective Properties in Ischemic Stroke in Rats , 2021, General Reanimatology.

[4]  D. Silachev,et al.  Effect of Xenon Treatment on Gene Expression in Brain Tissue after Traumatic Brain Injury in Rats , 2021, Brain sciences.

[5]  R. Diaz-Arrastia,et al.  Inhalational Gases for Neuroprotection in Traumatic Brain Injury. , 2021, Journal of neurotrauma.

[6]  D. Silachev,et al.  Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis , 2021, Brain sciences.

[7]  P. Bruneval,et al.  Argon Attenuates Multiorgan Failure in Relation with HMGB1 Inhibition , 2021, International journal of molecular sciences.

[8]  Hongliu Sun,et al.  The neuroprotective effect and possible therapeutic application of xenon in neurological diseases , 2021, Journal of neuroscience research.

[9]  Surojit Paul,et al.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies , 2020, Experimental Neurology.

[10]  G. Citerio,et al.  Efficacy of acute administration of inhaled argon on traumatic brain injury in mice. , 2020, British journal of anaesthesia.

[11]  D. Turner,et al.  Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice , 2020, Neurocritical Care.

[12]  А. М. Голубев Модели ишемического инсульта (обзор) , 2020 .

[13]  L. Rohrer,et al.  Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation , 2019, Nature Immunology.

[14]  M. Maze,et al.  Neuroprotective Properties of Xenon , 2019, Molecular Neurobiology.

[15]  Bo Hu,et al.  [Corrigendum] HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways. , 2019, International journal of molecular medicine.

[16]  R. Dickinson,et al.  Noble gas neuroprotection: xenon and argon protect against hypoxic–ischaemic injury in rat hippocampus in vitro via distinct mechanisms , 2019, British journal of anaesthesia.

[17]  K. Langen,et al.  Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study , 2019, Critical Care.

[18]  R. Dickinson,et al.  Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice , 2019, British journal of anaesthesia.

[19]  R. Dickinson,et al.  Xenon Protects against Blast-Induced Traumatic Brain Injury in an In Vitro Model , 2017, Journal of neurotrauma.

[20]  S. Lemoine,et al.  Argon Exposure Induces Postconditioning in Myocardial Ischemia–Reperfusion , 2017, Journal of cardiovascular pharmacology and therapeutics.

[21]  R. Rossaint,et al.  Argon attenuates the emergence of secondary injury after traumatic brain injury within a 2-hour incubation period compared to desflurane: an in vitro study , 2017, Medical gas research.

[22]  G. Landoni,et al.  Sevoflurane Versus Total Intravenous Anesthesia for Isolated Coronary Artery Bypass Surgery With Cardiopulmonary Bypass: A Randomized Trial. , 2016, Journal of cardiothoracic and vascular anesthesia.

[23]  R. Rossaint,et al.  Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning , 2016, International journal of molecular sciences.

[24]  T. Loop,et al.  Argon mediates protection by interleukin‐8 suppression via a TLR2/TLR4/STAT3/NF‐κB pathway in a model of apoptosis in neuroblastoma cells in vitro and following ischemia‐reperfusion injury in rat retina in vivo , 2016, Journal of neurochemistry.

[25]  Hailin Zhao,et al.  Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2 , 2016, Oncotarget.

[26]  R. Guieu,et al.  Effectiveness of pure argon for renal transplant preservation in a preclinical pig model of heterotopic autotransplantation , 2016, Journal of Translational Medicine.

[27]  T. Loop,et al.  Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4 , 2015, PloS one.

[28]  R. Rossaint,et al.  Neuroprotektion durch Edelgase , 2015, Der Anaesthesist.

[29]  T. Loop,et al.  Neuroprotective effects of Argon are mediated via an ERK‐1/2 dependent regulation of heme‐oxygenase‐1 in retinal ganglion cells , 2015, Journal of neurochemistry.

[30]  C. Meckler,et al.  Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens , 2015, Translational Psychiatry.

[31]  T. Loop,et al.  Argon Inhalation Attenuates Retinal Apoptosis after Ischemia/Reperfusion Injury in a Time- and Dose-Dependent Manner in Rats , 2014, PloS one.

[32]  R. Rossaint,et al.  Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats , 2014, Medical gas research.

[33]  R. Rossaint,et al.  Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening. , 2014, Resuscitation.

[34]  L. Galluzzi,et al.  Antiapoptotic activity of argon and xenon , 2013, Cell cycle.

[35]  Array В. Лихванцев,et al.  Влияние севофлурана на функциональное восстановление животных, перенесших системную остановку кровообращения , 2012 .

[36]  J. Risso,et al.  Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult , 2012, PloS one.

[37]  Rolf Rossaint,et al.  The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. , 2012, European journal of pharmacology.

[38]  A. A. Uchevatkin,et al.  Comparative Evaluation of Two Methods for Studies of Experimental Focal Ischemia: Magnetic Resonance Tomography and Triphenyltetrazoleum Detection of Brain Injuries , 2009, Bulletin of Experimental Biology and Medicine.

[39]  J. Risso,et al.  Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.